ImmunityBio Ownership | Who Owns ImmunityBio?


OverviewForecastRevenueFinancialsChart

ImmunityBio Ownership Summary


ImmunityBio is owned by 13.94% institutional investors, 69.20% insiders, and 16.86% retail investors. Vanguard group is the largest institutional shareholder, holding 2.49% of IBRX shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 0.77% of its assets in ImmunityBio shares.

IBRX Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockImmunityBio13.94%69.20%16.86%
SectorHealthcare Stocks 488.17%11.08%-399.26%
IndustryBiotech Stocks 306.59%11.10%-217.69%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Vanguard group17.33M2.49%$44.36M
Blackrock funding, inc. /de17.77M2.00%$46.91M
Blackrock11.42M1.70%$72.19M
State street7.86M1.17%$49.70M
Armistice capital7.76M0.87%$20.50M
Geode capital management3.84M0.55%$9.83M
Woodline partners lp3.44M0.49%$8.81M
Tang capital management2.33M0.26%$6.16M
Ubs group1.59M0.23%$4.06M
Charles schwab investment management1.28M0.18%$3.27M

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Armistice capital7.76M0.35%$20.50M
Tang capital management2.33M0.31%$6.16M
Accurate wealth management560.00K0.25%$1.61M
Clearwater capital advisors846.42K0.21%$2.17M
Sheets smith wealth management633.48K0.20%$1.67M
Allen inc /ny687.57K0.18%$1.82M
Virtus investment advisers139.31K0.12%$367.78K
Wealth effects122.00K0.12%$322.08K
Kercheville advisors100.50K0.09%$265.32K
Bell & brown wealth advisors77.75K0.07%$205.26K

Top Buyers

HolderShares% AssetsChange
Armistice capital7.76M0.35%7.76M
Blackrock funding, inc. /de17.77M0.00%4.48M
Woodline partners lp3.44M0.06%3.00M
Ubs group1.59M0.00%1.18M
Blackrock11.42M0.00%1.05M

Top Sellers

HolderShares% AssetsChange
State street7.86M0.00%-6.32M
Cormorant asset management, lp---3.00M
Octagon capital advisors lp---1.72M
Ubs asset management americas261.73K0.00%-1.28M
Perceptive advisors---1.22M

New Positions

HolderShares% AssetsChangeValue
Armistice capital7.76M0.35%7.76M$20.50M
Group one trading498.43K0.00%498.43K$1.28B
Hennion & walsh asset management180.52K0.02%180.52K$476.57K
Regions financial102.00K0.00%102.00K$269.28K
Kercheville advisors100.50K0.09%100.50K$265.32K

Sold Out

HolderChange
Sjs investment consulting-9.00
Investors research-15.00
Financial gravity asset management-17.00
Nelson, van denburg & campbell wealth management group-26.00
Global financial private client-32.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Jun 30, 202525415.45%123,819,65152.36%1315.36%15932.50%37-13.95%
Mar 31, 20252204.27%81,251,228-1.72%96.75%1196.25%44-
Dec 31, 2024120-36.84%47,071,266-31.49%66.94%60-27.71%25-40.48%
Sep 30, 2024189-8.25%68,622,14511.64%912.32%85-23.42%41-12.77%
Jun 30, 202420412.09%61,450,416-7.05%95.41%11023.60%4711.90%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv7.29M0.77%-161.55K
Vanguard US Total Market Shares ETF5.72M0.67%1.43M
iShares Russell 2000 ETF5.36M0.57%-101.95K
Vanguard Small Cap Index5.36M0.57%-35.92K
SPDR® S&P Biotech ETF3.06M0.35%75.57K
Vanguard Small Cap Growth Index Inv3.00M0.32%-5.35K
Vanguard Institutional Extnd Mkt Idx Tr2.19M0.23%-994.29K
Fidelity Small Cap Index1.55M0.18%-4.93K
iShares Russell 2000 Growth ETF1.65M0.17%-
JPM Thematics Genetic Thrps C2 Acc USD878.86K0.13%-30.90K

Recent Insider Transactions


DateNameRoleActivityValue
Sep 11, 2023SOON-SHIONG PATRICK See remarksBuy-
Jun 05, 2023BLASZYK MICHAEL D-Buy$132.96K
Jun 05, 2023BLASZYK MICHAEL D-Buy$1.33K
Jun 05, 2023BLASZYK MICHAEL D-Buy$63.73K
Jun 02, 2023Brennan John Owen-Buy$29.00K

Insider Transactions Trends


DateBuySell
2025 Q2--
2025 Q1--
2024 Q4--
2024 Q2--
2024 Q1--

IBRX Ownership FAQ


Who Owns ImmunityBio?

ImmunityBio shareholders are primarily institutional investors at 13.94%, followed by 69.20% insiders and 16.86% retail investors. The average institutional ownership in ImmunityBio's industry, Biotech Stocks , is 306.59%, which ImmunityBio falls below.

Who owns the most shares of ImmunityBio?

ImmunityBio’s largest shareholders are Vanguard group (17.33M shares, 2.49%), Blackrock funding, inc. /de (17.77M shares, 2.00%), and Blackrock (11.42M shares, 1.70%). Together, they hold 6.19% of ImmunityBio’s total shares outstanding.

Does Blackrock own ImmunityBio?

Yes, BlackRock owns 1.70% of ImmunityBio, totaling 11.42M shares as of Jun 2024. This represents 0.00% of BlackRock's total assets, with a market value of 72.19M$. In the last quarter, BlackRock increased its holdings by 1.05M shares, a 10.10% change.

Who is ImmunityBio’s biggest shareholder by percentage of total assets invested?

Armistice capital is ImmunityBio’s biggest shareholder by percentage of total assets invested, with 0.35% of its assets in 7.76M ImmunityBio shares, valued at 20.5M$.

Who is the top mutual fund holder of ImmunityBio shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of ImmunityBio shares, with 0.77% of its total shares outstanding invested in 7.29M ImmunityBio shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools